JPRN-UMIN000045064
Recruiting
Phase 2
A Prospective Clinical Trial of Proton Radiotherapy with 12 fractions for Patients with Prostate Cancer - Proton Radiotherapy with 12 fractions for Prostate Cancer
arita Memorial Proton Center0 sites200 target enrollmentAugust 16, 2021
ConditionsProstate cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- arita Memorial Proton Center
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patient without tissue specimen of biopsy 2\)Patient with past history of radiotherapy for the targeted lesion 3\)Patient with past history of surgery for the target lesion 4\)Patient with active and intractable infection in the targeted lesion 5\)Patient who is administrated more than two anticoagulant drugs 6\)Inflammatory bowel diseases or after the surgery of rectal cancer 7\)Patient who cannot be put the metal marker or spacer 8\)Patient with severe disease 9\) Judged as inappropriate to participation by investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinomaJPRN-UMIN000002863Proton Medical Research Center, University of Tsukuba10
Recruiting
Phase 2
Phase II non-randomized study on proton radiotherapy of thymic malignanciescancerThymoma10027655NL-OMON51962Swedish Lung Cancer Study Group10
Recruiting
Not Applicable
Multicenter registry study on proton radiotherapy of mediastinal lymphomaC85.2Mediastinal (thymic) large B-cell lymphomaDRKS00015660niversitätsklinikum Heidelberg; Abteilung für RadioOnkologie und Strahlentherapie300
Recruiting
Not Applicable
Randomized trial of radiotherapy with protons vs. radiotherapy with photons for patients with WHO grade II-III gliomaC71Malignant neoplasm of brainDRKS00015160Abteilung Klinische Neuroonkologie, Klinik für Neurologie, Universitätsklinikum Essen80
Not yet recruiting
Not Applicable
A clinical study on safety and efficacy of proton pump inhibitor with Yukgunja-tang for refractory gastroesophageal reflux diseaseDiseases of the digestive systemKCT0008600Kyunghee University-industry Cooperation Foundation86